Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma
Wenting Li, Xiaobing Duan, Xingxing Chen, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Epstein-Barr virus infection: the micro and macro worlds
Wei Huang, Lang Bai, Hong Tang
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 24
Treatment of Epstein-Barr Virus infection in immunocompromised patients
Martyna Pociupany, Robert Snoeck, Daan Dierickx, et al.
Biochemical Pharmacology (2024) Vol. 225, pp. 116270-116270
Closed Access | Times Cited: 6
EBV promotes TCR-T-cell therapy resistance by inducing CD163+M2 macrophage polarization and MMP9 secretion
Yuanyuan Chen, Dijun Ouyang, Yan Wang, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 6, pp. e008375-e008375
Open Access | Times Cited: 6
Specific Immune Responses and Oncolytic Effects Induced by EBV LMP2A-Armed Modified Ankara-Vaccinia Virus Vectored Vaccines in Nasopharyngeal Cancer
Liying Sun, Chao Liu, Junping Peng
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 52-52
Open Access
Epstein-Barr virus-infected nasopharyngeal carcinoma therapeutics: oncoprotein targets and clinical implications
Jacqueline Kar Kei Mark, Aik-Hong Teh, Beow Keat Yap
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access
Human T‐cell leukemia virus type 1‐associated myelopathy/tropical spastic paraparesis and multiple sclerosis: Viral strategies and their implications
Makoto Nakashima, Yoshihisa Yamano
Clinical and Experimental Neuroimmunology (2025)
Closed Access
Neutrophil‐to‐Lymphocyte Ratio as a Predictor for PD‐L1 Inhibitor Treatment in Recurrent or Metastatic Nasopharyngeal Carcinoma
Kun Gao, Zhigong Wei, Zheran Liu, et al.
Head & Neck (2025)
Closed Access
Infectious mononucleosis is a more realistic target for preventing multiple sclerosis
Gavin Giovannoni, Christopher H. Hawkes, Jeannette Lechner‐Scott, et al.
Multiple Sclerosis and Related Disorders (2025) Vol. 95, pp. 106337-106337
Closed Access
The key role of DLX6 in nasopharyngeal carcinoma: metastasis, angiogenesis and tumor immune mechanism
Hanxuan Yang, Ximing Zeng, Xiaochuan Chen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
LMP2-mRNA lipid nanoparticle sensitizes EBV-related tumors to anti-PD-1 therapy by reversing T cell exhaustion
Xiang Yu, Miaomiao Tian, Juan Huang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 11
Paclitaxel in colon cancer management: from conventional chemotherapy to advanced nanocarrier delivery systems
Komal Komal, Bibhu Prasad Nanda, L. Singh, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 12, pp. 9449-9474
Closed Access | Times Cited: 3
The Impact of Oral Microbiome Dysbiosis on the Aetiology, Pathogenesis, and Development of Oral Cancer
Jasminka Talapko, Suzana Erić, Tomislav Meštrović, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 2997-2997
Open Access | Times Cited: 2
The Role of NK Cells in EBV Infection and Related Diseases: Current Understanding and Hints for Novel Therapies
Maria Giovanna Desimio, Daniela Angela Covino, Beatrice Rivalta, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1914-1914
Open Access | Times Cited: 7
Pathogenesis and therapeutic implications of EBV-associated epithelial cancers
Yi Hua Low, Celestine Jia Ling Loh, Daniel Yang Yao Peh, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
Single cell analysis unveils the commonality and heterogeneity between nasopharyngeal and oropharyngeal carcinoma
Liping Wang, Shuang Li, Xinran Li, et al.
Neoplasia (2024) Vol. 50, pp. 100980-100980
Open Access | Times Cited: 1
Dihydrotestosterone Enhances MICA-Mediated Immune Responses to Epstein–Barr Virus-Associated Gastric Carcinoma
Dong‐Hyun Seo, Hyeji Byun, Miyeon Cho, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3219-3219
Open Access | Times Cited: 1
Hypoxia Induces Tumor-Derived Exosome SNHG16 to Mediate Nasopharyngeal Carcinoma Progression through the miR-23b-5p/MCM6 Pathway
Wei Hou, Lu Xu, Tao Su, et al.
Applied Biochemistry and Biotechnology (2023)
Closed Access | Times Cited: 4
The whole-blood Epstein-Barr virus DNA can serve as a valuable molecular marker for diagnosis and prognosis prediction of nasopharyngeal carcinoma.
Meichun Zeng, Qingjun Jia, Jue Xu, et al.
PubMed (2023) Vol. 13, Iss. 11, pp. 5431-5442
Closed Access | Times Cited: 3
Nasopharyngeal Carcinoma: Case Presentation and Literature Review of Treatment Innovation with Immunotherapy
Somtochi Okafor, Jameel Muzaffar, David W. Jang, et al.
Journal of Neurological Surgery Reports (2023) Vol. 84, Iss. 03, pp. e113-e115
Open Access | Times Cited: 2
Research progress and application of single-cell sequencing in head and neck malignant tumors
Siyuan Qu, Mengdan Gong, Yongqin Deng, et al.
Cancer Gene Therapy (2023) Vol. 31, Iss. 1, pp. 18-27
Open Access | Times Cited: 2
MiRNA signatures in nasopharyngeal carcinoma: molecular mechanisms and therapeutic perspectives.
Yan Chen, Ting Lin, Le Tang, et al.
PubMed (2023) Vol. 13, Iss. 12, pp. 5805-5824
Closed Access | Times Cited: 2
A novel EIF3C-related CD8+ T-cell signature in predicting prognosis and immunotherapy response of nasopharyngeal carcinoma
Rui Li, Yikai Wang, Xin Wen, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 2
Open Access
Analysis and Development of Antigen-specific T Cells Derived from Peripheral Blood Mononuclear Cells of Healthy Donors
J C Kim, SUNGWOOK JUNG, Byung-Kwan Jeong, et al.
Anticancer Research (2024) Vol. 44, Iss. 4, pp. 1377-1387
Open Access
The efficacy and safety of EGFR‐TKI in recurrent/metastatic nasopharyngeal carcinoma patients: A systematic review and meta‐analysis
Zeqi An, Libin He, Tuo Chen, et al.
Laryngoscope Investigative Otolaryngology (2024) Vol. 9, Iss. 3
Open Access
Structure-Based Discovery of Potential HPV E6 and EBNA1 Inhibitors: Implications for Cervical Cancer Treatment
Emmanuel Broni, Carolyn Ashley, Miriam Velazquez, et al.
Computation (2024) Vol. 12, Iss. 6, pp. 112-112
Open Access
Page 1 - Next Page

Scroll to top